FTSE All-Share
4 341,85
|
-222,46
|
-4,87%
|
Analysen zu FTSE All-Share-Werten
03.03.25 | Shell Buy | Goldman Sachs Group Inc. | |
03.03.25 | Diageo Hold | Deutsche Bank AG | |
28.02.25 | BP Buy | UBS AG | |
28.02.25 | London Stock Exchange Hold | Deutsche Bank AG | |
28.02.25 | Glencore Buy | Deutsche Bank AG | |
28.02.25 | Glencore Outperform | RBC Capital Markets | |
28.02.25 | Rio Tinto Sector Perform | RBC Capital Markets | |
28.02.25 | London Stock Exchange Overweight | JP Morgan Chase & Co. | |
27.02.25 | BP Verkaufen | DZ BANK | |
27.02.25 | BP Buy | Jefferies & Company Inc. | |
27.02.25 | BP Buy | Goldman Sachs Group Inc. | |
27.02.25 | London Stock Exchange Buy | Goldman Sachs Group Inc. | |
27.02.25 | BP Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
27.02.25 | London Stock Exchange Outperform | RBC Capital Markets | |
27.02.25 | London Stock Exchange Buy | Jefferies & Company Inc. | |
27.02.25 | London Stock Exchange Buy | UBS AG | |
27.02.25 | BP Buy | Jefferies & Company Inc. | |
27.02.25 | BP Neutral | JP Morgan Chase & Co. | |
26.02.25 | BP Sector Perform | RBC Capital Markets | |
26.02.25 | BP Sector Perform | RBC Capital Markets | |
26.02.25 | BP Buy | UBS AG | |
26.02.25 | BP Buy | Jefferies & Company Inc. | |
26.02.25 | HSBC Holdings Neutral | JP Morgan Chase & Co. | |
26.02.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
26.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
26.02.25 | HSBC Holdings Sector Perform | RBC Capital Markets | |
26.02.25 | Unilever Buy | Deutsche Bank AG | |
26.02.25 | London Stock Exchange Overweight | JP Morgan Chase & Co. | |
26.02.25 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
26.02.25 | London Stock Exchange Buy | UBS AG | |
25.02.25 | Unilever Sell | UBS AG | |
25.02.25 | Shell Outperform | RBC Capital Markets | |
25.02.25 | Unilever Kaufen | DZ BANK | |
25.02.25 | Unilever Outperform | Bernstein Research | |
25.02.25 | Unilever Underperform | Jefferies & Company Inc. | |
25.02.25 | Unilever Sell | UBS AG | |
25.02.25 | Unilever Overweight | JP Morgan Chase & Co. | |
25.02.25 | BAT Neutral | JP Morgan Chase & Co. | |
25.02.25 | London Stock Exchange Overweight | JP Morgan Chase & Co. | |
25.02.25 | Unilever Underperform | RBC Capital Markets |